24 reports

Abstract: - Global Hyperlipidemia Drugs Market to Reach $24.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hyperlipidemia Drugs estimated at US$20.1 Billion in the year 2020, is projected to reach a revised size of US$24.1 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027....

  • Cardiovascular Disease
  • World
  • China
  • United States

The global hyperlipidemia drugs market reached a value of US$ 21.7 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 24.8 Billion by 2027, exhibiting a CAGR of 2.17% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Cardiovascular Disease
  • World

The global antihyperlipidemic drugs market reached a value of US$ 11.31 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 15.81 Billion by 2027, exhibiting a CAGR of 5.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...

  • Lipid Modifying Drug
  • World
  • Hospital Occupancy Rate
  • Mortality Rate

Major players in the hypolipidemic drugs market are Abbott Laboratories Limited, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited, Chunghwa Chem Syn& Biotech Co. Ltd, Concord Biotech Limited, Croda Europe Limited Leek, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, DSM Sinochem Pharma India, Hikal, Ipca Laboratories,...

  • Pharmaceutical
  • Clinical Trial
  • Cholesterol
  • Statins
  • World
  • India
  • United States
  • European Union
  • Middle East
  • APAC
  • Dropout Rate
  • Smoking Prevalence

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cholangitis - Drugs in Development by Stages, Target, MoA,...

  • Autoimmune Disease
  • Digestive System Disorder
  • World
  • South Africa
  • Medical Technology Density
  • Lead Export

Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Drugs In Development, 2021, provides an overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape.Hypercholesterolemia...

  • Cardiovascular Disease
  • Drug Development
  • World
  • China
  • Pharmaceutical Registrations
  • Drug Approval

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cholangitis - Drugs in Development, 2021, provides an overview of the Primary Biliary Cholangitis (Gastrointestinal)...

  • Digestive System Disorder
  • Drug Development
  • Autoimmune Disease
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Hypercholesterolemia - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Pipeline Review, H2 2020, provides an overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape. Hypercholesterolemia is a condition...

  • Cardiovascular Disease
  • Pharmaceutical Registrations
  • Drug Approval

Cholesterol Lowering Drugs Market – Scope of the Report This report on the global cholesterol lowering drugs market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.The report provides the...

  • Cholesterol
  • World

Antihyperlipidemic Drugs Market by Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, and Combination): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global antihyperlipidemic drugs market accounted for $9,456 million in 2018,...

  • Lipid Modifying Drug
  • World
  • APAC
  • Europe

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cholangitis - Pipeline Review, H2 2020, provides an overview of the Primary Biliary Cholangitis (Gastrointestinal) pipeline...

  • Digestive System Disorder
  • Autoimmune Disease
  • World
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Hypercholesterolemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia – Pipeline Review, H1 2020, provides an overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape. Hypercholesterolemia is...

  • Cardiovascular Disease
  • World
  • China
  • Pharmaceutical Registrations
  • Drug Approval

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H1 2020 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cholangitis - Pipeline Review, H1 2020, provides an overview of the Primary Biliary Cholangitis (Gastrointestinal) pipeline...

  • Digestive System Disorder
  • Autoimmune Disease
  • World
  • South Africa
  • Drug Approval
  • Health Provider Density

Report Scope: Five-year projections for market activity and value are provided. Treatment types and trends for acute and chronic kidney failure, pricing considerations for medications, dialysis products (dialysis machines, dialysates and dialyzers), therapies, surgical procedures, companies, industry structure and participating...

  • Healthcare
  • Medical Device
  • Dialysis Device
  • Chronic Disease
  • Transplantation
  • World

Primary Biliary Cirrhosis - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cirrhosis - Pipeline Review, H1 2019, provides an overview of the Primary Biliary Cirrhosis (Gastrointestinal) pipeline landscape. Primary...

  • Autoimmune Disease
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Primary Biliary Cirrhosis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cirrhosis - Pipeline Review, H2 2018, provides an overview of the Primary Biliary Cirrhosis (Gastrointestinal) pipeline landscape. Primary...

  • Autoimmune Disease
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

##.##.## Bile Acid Sequestrants

  • Therapy
  • World
  • Southeast Asia
  • Drug Approval
  • Inflation Rate

“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology ( Prevalence of Type 1 & 2 Diabetes) in the US market along with the associated economic burden and productivity loss. Diabetes...

  • Antidiabetics
  • Diabetes
  • Insulin
  • United States
  • Diabetes Prevalence

This report analyzes the worldwide markets for Cholesterol Testing in Thousands of Cholesterol Tests by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America,...

  • Cholesterol
  • Clinical Diagnostic
  • World
  • APAC

Bile acid sequestrants

  • Cardiovascular Disease
  • Therapy
  • Statins
  • Chronic Disease
  • Clinical Trial
  • World
  • Drug Approval
  • Chronic Disease Prevalence

## Bile Acid Sequestrants

  • Cholesterol
  • United States
  • Japan
  • China
  • Overweight Prevalence
  • Urban Population

This BCC Research report provides a comprehensive analysis of the renal disease market and its trends from 2016 through 2021. In-depth analysis is provided on predominant treatment of kidney diseases, including pharmaceutical medication, renal replacement therapy, and kidney transplantation. Use this report to: Analyze...

  • Chronic Disease
  • Renal Disease
  • United States

##.##.## Bile Acid Sequestrants

  • Therapy
  • World
  • Diabetes Prevalence
  • Drug Approval